MARAbio is a biotech firm that works to detect and prevent severe forms of Autism.
MARAbio has raised $19.1M in total funding. The most recent round was Series A. The last funding was announced in October 2024.
MARAbio's investors include Autism Impact Fund, Mesa Verde Venture Partners, MAK Capital, David Carrico.
MARAbio is headquartered in Salt Lake City, United States.
MARAbio is a biotech firm that works to detect and prevent severe forms of Autism.
MARAbio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MARAbio — Funding & Investors." VCBacked, October 7, 2024, https://www.vcbacked.co/company/marabio. Accessed August 14, 2026.
VCBacked. (2024). MARAbio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/marabio
{{cite web |title=MARAbio — Funding & Investors |url=https://www.vcbacked.co/company/marabio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated